Eliem Therapeutics, Inc (ELYM) Financials
ELYM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 112.7 million | 3.0 million |
| 2023-06-30 | 116.3 million | 3.8 million |
| 2023-03-31 | 122.1 million | 5.2 million |
| 2022-12-31 | 135.0 million | 6.3 million |
ELYM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | 3.5 million | 656000 |
| 2023-06-30 | -8.0 million | 777000 |
| 2023-03-31 | -15.2 million | 10.2 million |
| 2022-12-31 | -8.4 million | 1.9 million |
ELYM Net Income
No data available :(
ELYM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 107.4 million | - | 459000 |
| 2023-06-30 | 102.6 million | - | 585000 |
| 2023-03-31 | 109.4 million | - | 687000 |
| 2022-12-31 | 123.6 million | - | 480000 |
ELYM Shares Outstanding
ELYM Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 2.9 million | 2.1 million | - |
| 2023-06-30 | - | 3.7 million | 3.0 million | - |
| 2023-03-31 | - | 5.7 million | 17.7 million | - |
| 2022-12-31 | - | 4.9 million | 4.6 million | - |
ELYM Cost of Revenue
No data available :(
ELYM
Price: $7.57
52 week price:
Earnings Per Share: -1.30 USD
P/E Ratio: -1.85
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 3200
Market Capitalization: 119.5 million